SOCS1 and Hyperglycemia: We also tracked diabetes development in the infected SOCS1-tg mice until day 21 p.i. As expected, diabetes occurred in the buffer-treated SOCS1-tg mice with 50% (3/6) developing hyperglycaemia (p < 0.05; Fig. 2f).